Mgr. Karla Plevová, Ph.D.

Head of the research group, Karla Plevová Research Group: Genomics of Immune Cells

correspondence Address:
Jihlavská 340/20, 625 00 Brno

office: bldg. E35/258
Kamenice 753/5
625 00 Brno

phone:	+420 532 23 4396
e‑mail:
web:	https://genomika.med.muni.cz/research/research-groups/karla-plevova-group/about-us

social and academic networks:

Basic information

Supervision

Qualifications

Publications

Type

Total number of publications: 359

2023

Clonal competition and disrupted molecular processes in chronic lymphocytic leukemia.

ZÁVACKÁ Kristýna TAUŠ Petr PÁL Karol PORC Jakub Paweł PAVLOVÁ Šárka MALČÍKOVÁ Jitka STRÁNSKÁ Kamila ŽENATOVÁ Marcela TICHÝ Boris BLAVET Nicolas PANOVSKÁ Anna DOUBEK Michael POSPÍŠILOVÁ Šárka PLEVOVÁ Karla

Conference abstract

Year: 2023, type: Conference abstract
Comprehensive NGS testing allows integrated assessment of individual patient prognosis in multiple myeloma.

KOTAŠKOVÁ Jana MAREČKOVÁ Andrea POKRIVČÁKOVÁ Daniela ONDROUŠKOVÁ Eva HRABČÁKOVÁ Viera NAVRKALOVÁ Veronika PORC Jakub Paweł PLEVOVÁ Karla JAROŠOVÁ Marie POSPÍŠILOVÁ Šárka ŠTORK Martin POUR Luděk

Conference abstract

Year: 2023, type: Conference abstract
Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damage

MANČÍKOVÁ Veronika PEŠOVÁ Michaela PAVLOVÁ Šárka HELMA Robert ZÁVACKÁ Kristýna HEJRET Václav TAUŠ Petr HYNŠT Jakub PLEVOVÁ Karla MALČÍKOVÁ Jitka POSPÍŠILOVÁ Šárka

Article in Periodical

MOLECULAR ONCOLOGY, year: 2023, volume: 17, edition: 1, DOI
Distinct p53 Phosphorylation Patterns in Chronic Lymphocytic Leukemia: Where They Come from and How They Affect p53 Function.

PEŠOVÁ Michaela MANČÍKOVÁ Veronika HELMA Robert PAVLOVÁ Šárka HEJRET Václav TAUŠ Petr HYNŠT Jakub PLEVOVÁ Karla KOTAŠKOVÁ Jana MALČÍKOVÁ Jitka POSPÍŠILOVÁ Šárka

Conference abstract

Year: 2023, type: Conference abstract
Enhanced in vitro culture of leukemic cells: Insights from collagen scaffolds and carboxymethyl cellulose-polyethylene glycol gel.

SVOZILOVÁ Hana VOJTOVÁ Lucy DORAZILOVÁ Jana BRUKNEROVÁ Jana POLÁKOVÁ Veronika RADOVÁ Lenka DOUBEK Michael PLEVOVÁ Karla POSPÍŠILOVÁ Šárka

Conference abstract

Year: 2023, type: Conference abstract
Exploring patterns in clinical, biological, and molecular data of leukemia patients with CLLue.

REIGL Tomáš NAVRKALOVÁ Veronika PORC Jakub Paweł PÁL Karol STRÁNSKÁ Kamila POSPÍŠILOVÁ Šárka PLEVOVÁ Karla

Conference abstract

Year: 2023, type: Conference abstract
FOX01-rictor AXIS induces AKT phosporylation during CLL cell adaptation to BCR inhibitors: Implications for combinatorial therapy.

ONDRIŠOVÁ Laura ŠEDA Václav HOFERKOVÁ Eva CHIODIN G. HLAVÁČ Kryštof KOŠŤÁLOVÁ Lenka MLADONICKÁ PAVLASOVÁ Gabriela FILIP Daniel FARIA ZENI Pedro OPPELT Jan PANOVSKÁ Anna PLEVOVÁ Karla POSPÍŠILOVÁ Šárka SIMKOVIC M. VRBACKÝ F. LYSÁK Daniel FERNANDES SM. DAVIDS MS. MAIQUES-DIAZ A. CHARALAMPOPOULOU S. MARTIN-SUBERO JI. BROWN JR. DOUBEK Michael FORCONI F. MAYER Jiří MRÁZ Marek

Conference abstract

Year: 2023, type: Conference abstract
FOXO1-RICTOR AXIS induces adaptive increase in AKT activity during BCR inhibitor therapy in CLL: Implications for combination therapy.

ONDRIŠOVÁ Laura ŠEDA Václav CHIODIN Giorgia HLAVÁČ Kryštof KOŠŤÁLOVÁ Lenka FILIP Daniel FARIA ZENI Pedro PANOVSKÁ Anna PLEVOVÁ Karla POSPÍŠILOVÁ Šárka ŠIMKOVIČ Martin VRBACKÝ Filip LYSÁK Daniel FERNANDEZ Stacey M. DAVIDS MS. MAIQUES-DIAZ Alba CHARALAMPOPOULOU Stella MARTIN-SUBERO Jose I. BROWN Jennifer R. DOUBEK Michael FORCONI Francesco MAYER Jiří MRÁZ Marek

Conference abstract

Year: 2023, type: Conference abstract
Foxo1-Rictor axis mediates adaptive increase in Akt activity and cell survival during BCR inhibitor therapy in chronic lymphocytic leukemia.

HLAVÁČ Kryštof ONDRIŠOVÁ Laura ŠEDA Václav HOFERKOVÁ Eva CHIODIN G. KOŠŤÁLOVÁ Lenka MLADONICKÁ PAVLASOVÁ Gabriela FILIP Daniel FARIA ZENI Pedro OPPELT Jan PANOVSKÁ Anna PLEVOVÁ Karla POSPÍŠILOVÁ Šárka ŠIMKOVIČ M. VRBACKÝ F. LYSÁK Daniel FERNANDES SM. DAVIDS MS. MAIQUES-DIAZ A. CHARALAMPOPOULOU S. MARTIN-SUBERO I. BROWN JR. DOUBEK Michael FORCONI Francesco MAYER Jiří MRÁZ Marek

Conference abstract

Year: 2023, type: Conference abstract
Hide and seek retroelement activity in hematological malignancies.

VOLAKHAVA Anastasiya PAVLOVÁ Šárka ZÁVACKÁ Kristýna PÁL Karol KRZYŽÁNKOVÁ Marcela SYNÁČKOVÁ Hana POSPÍŠILOVÁ Šárka MAMEDOV Ilgar PLEVOVÁ Karla

Conference abstract

Year: 2023, type: Conference abstract

Projects

Teaching

10 reasons why you will fall in love with MU

Ask our ambassador

Read about research at MU

Mgr. Karla Plevová, Ph.D.

2023

Clonal competition and disrupted molecular processes in chronic lymphocytic leukemia.

Comprehensive NGS testing allows integrated assessment of individual patient prognosis in multiple myeloma.

Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damage

Distinct p53 Phosphorylation Patterns in Chronic Lymphocytic Leukemia: Where They Come from and How They Affect p53 Function.

Enhanced in vitro culture of leukemic cells: Insights from collagen scaffolds and carboxymethyl cellulose-polyethylene glycol gel.

Exploring patterns in clinical, biological, and molecular data of leukemia patients with CLLue.

FOX01-rictor AXIS induces AKT phosporylation during CLL cell adaptation to BCR inhibitors: Implications for combinatorial therapy.

FOXO1-RICTOR AXIS induces adaptive increase in AKT activity during BCR inhibitor therapy in CLL: Implications for combination therapy.

Foxo1-Rictor axis mediates adaptive increase in Akt activity and cell survival during BCR inhibitor therapy in chronic lymphocytic leukemia.

Hide and seek retroelement activity in hematological malignancies.